Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Aggressive Hybrid Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential Equity & Debt Fund |
|---|---|
| 07 Jan 2013 | ₹100.00 |
| 25 Feb 2014 | ₹110.58 |
| 16 Apr 2015 | ₹154.27 |
| 03 Jun 2016 | ₹146.08 |
| 23 Jul 2017 | ₹179.95 |
| 10 Sep 2018 | ₹180.30 |
| 30 Oct 2019 | ₹171.82 |
| 17 Dec 2020 | ₹184.60 |
| 04 Feb 2022 | ₹258.98 |
| 26 Mar 2023 | ₹259.56 |
| 13 May 2024 | ₹361.42 |
| 02 Jul 2025 | ₹408.72 |
| 20 Aug 2026 | ₹413.77 |
| Metric | ICICI Prudential · Direct · IDCW NAV ₹71.21 High risk ★★★★☆ | Category median Aggressive Hybrid Fund · 46 funds |
|---|---|---|
| +0.71% | -0.13% | |
| +11.99% | +8.71% | |
| +12.78% | +9.07% | |
| +9.85% | +6.41% | |
| +10.99% | +8.71% | |
| +10.30% | — | |
| +11.29% | +9.75% | |
| +10.58% | +10.21% | |
| +10.83% | +7.64% | |
| Risk | ||
| 9.96% | 11.39% | |
| 0.55 | 0.19 | |
| 0.76 | 0.26 | |
| -36.85% | -30.66% | |
| Nifty 50 | — | |
| +3.62% | +0.53% | |
| 0.74 | 0.79 | |
| 88.5% | 83.6% | |
| 58.5% | 66.2% | |
| 1.05% | 1.10% | |
| — | ₹701.99Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 62% | 37% | |
| Sharmila D'silva | — | |
| 07 Jan 2013 | — | |
| 122 | — | |
| 35.3% | — | |
| 2.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.